#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Nephroblastoma Hypochromic anaemia Malformation venous Hereditary ataxia Necrotising myositis Small intestine adenocarcinoma Isodicentric chromosome 15 syndrome Arginase deficiency Endometrial cancer Ocular lymphoma Metastases to peritoneum Peritoneal neoplasm Synovial sarcoma recurrent Turner's syndrome Ovarian epithelial cancer More trials…

    Learn about Rare Diseases

    Primary mediastinal large B-cell lymphoma Marfan’s syndrome – Diagnostics Inclusion body myositis – Life with Disease Idiopathic pulmonary fibrosis – Basic Information Haemolytic uraemic syndrome Rhabdomyosarcoma – Basic Information Factor IX deficiency – Treatment Biotinidase deficiency – Diagnostics Focal segmental glomerulosclerosis – Life with Disease Haemophilia B without inhibitors – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gs-5245 Dactinomycin Sonidegib Azelastine MARALIXIBAT HUMAN FIBROBLASTS Cetirizine Dihydrochloride Isoniazid OSIMERTINIB MESYLATE Cagrilintide OMECAMTIV MECARBIL Prasinezumab Reboxetine [11C]Az14193391 CITRIC ACID ANHYDROUS Ilofotase Alfa Rbl016.2 Zetomipzomib Dl-Alpha Tocopherol Acetate Sodium Valproate More therapies…

    Learn about Your Condition

    Appendicitis perforated Pseudoxanthoma elasticum Diverticulitis Mesothelioma Substance use disorder Fallopian tube cancer Hot flush Colorectal cancer stage III Dystonia Hepatorenal syndrome HIV infection Small intestine carcinoma Eructation Herpes zoster Infectious pleural effusion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hypochondroplasia

  • Long‑Term Safety and Efficacy of Infigratinib in Children with Hypochondroplasia

    Recruiting

    2 1 1
    Investigated Drugs:
    • Infigratinib
    Norway Spain

  • Long-Term Study of Vosoritide Safety and Effectiveness in Children with Hypochondroplasia Until Adult Height is Reached

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypochondroplasia
    Investigated Drugs:
    • Vosoritide
    France Germany Italy Spain

  • Study on the Effectiveness and Safety of Infigratinib for Children with Hypochondroplasia and Short Stature

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hypochondroplasia
    Investigated Drugs:
    • Infigratinib
    • Placebo
    France Norway Portugal Spain Sweden

  • Study of Vosoritide Safety and Effectiveness in Infants and Young Children (0 to 36 months) with Hypochondroplasia

    Recruiting

    2 1 1
    Investigated Drugs:
    • Vosoritide
    France Germany Italy

  • Study on the Effectiveness and Safety of Vosoritide for Children with Hypochondroplasia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypochondroplasia
    Investigated Drugs:
    • Vosoritide
    France Germany Italy Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!